BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30641523)

  • 1. Parathyroid Carcinoma.
    Cetani F; Pardi E; Marcocci C
    Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on parathyroid carcinoma.
    Cetani F; Pardi E; Marcocci C
    J Endocrinol Invest; 2016 Jun; 39(6):595-606. PubMed ID: 27001435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid carcinoma: a clinical and genetic perspective.
    Cetani F; Pardi E; Marcocci C
    Minerva Endocrinol; 2018 Jun; 43(2):144-155. PubMed ID: 28949121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone.
    Cetani F; Pardi E; Marcocci C
    Endocrinol Metab Clin North Am; 2021 Dec; 50(4):683-709. PubMed ID: 34774241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid carcinoma.
    Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to the Patient With Parathyroid Carcinoma.
    Cetani F; Pardi E; Torregrossa L; Borsari S; Pierotti L; Dinoi E; Marcocci C
    J Clin Endocrinol Metab; 2023 Dec; 109(1):256-268. PubMed ID: 37531615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid cancer: An update.
    Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
    Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid carcinoma: molecular therapeutic targets.
    Marini F; Giusti F; Palmini G; Aurilia C; Donati S; Brandi ML
    Endocrine; 2023 Sep; 81(3):409-418. PubMed ID: 37160841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas.
    Wang O; Wang C; Nie M; Cui Q; Guan H; Jiang Y; Li M; Xia W; Meng X; Xing X
    PLoS One; 2012; 7(9):e45567. PubMed ID: 23029104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parathyroid carcinoma].
    Krysiak R; Okopień B
    Pol Merkur Lekarski; 2007 Aug; 23(134):145-50. PubMed ID: 18044348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete genomic landscape of a recurring sporadic parathyroid carcinoma.
    Kasaian K; Wiseman SM; Thiessen N; Mungall KL; Corbett RD; Qian JQ; Nip KM; He A; Tse K; Chuah E; Varhol RJ; Pandoh P; McDonald H; Zeng T; Tam A; Schein J; Birol I; Mungall AJ; Moore RA; Zhao Y; Hirst M; Marra MA; Walker BA; Jones SJ
    J Pathol; 2013 Jul; 230(3):249-60. PubMed ID: 23616356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid cancer.
    Sharretts JM; Kebebew E; Simonds WF
    Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and Epigenetics of Parathyroid Carcinoma.
    Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
    Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological correlates of hyperparathyroidism.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid Carcinoma: Diagnosis and Clinical Implications.
    Duan K; Mete Ö
    Turk Patoloji Derg; 2015; 31 Suppl 1():80-97. PubMed ID: 26177319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
    Westin G
    J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the treatment of parathyroid carcinoma: a case report.
    Russo M; Borzì G; Ilenia M; Frasca F; Malandrino P; Gullo D
    Hormones (Athens); 2019 Sep; 18(3):325-328. PubMed ID: 30905030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
    Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
    Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
    Hu Y; Zhang X; Wang O; Bi Y; Xing X; Cui M; Wang M; Tao W; Liao Q; Zhao Y
    Int J Cancer; 2020 Nov; 147(9):2446-2457. PubMed ID: 32574388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.